HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 202 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q3 2023. The put-call ratio across all filers is 0.36 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,533,153 | +9.2% | 290,911 | +17.2% | 0.00% | +50.0% |
| Q2 2023 | $8,733,278 | +19.5% | 248,175 | +10.8% | 0.00% | 0.0% |
| Q1 2023 | $7,310,629 | -41.2% | 223,909 | -0.8% | 0.00% | -50.0% |
| Q4 2022 | $12,435,629 | +9.8% | 225,692 | -11.7% | 0.00% | 0.0% |
| Q3 2022 | $11,325,000 | -1.3% | 255,706 | +8.7% | 0.00% | 0.0% |
| Q2 2022 | $11,478,000 | -9.4% | 235,324 | -9.6% | 0.00% | 0.0% |
| Q1 2022 | $12,669,000 | +11.3% | 260,391 | -2.5% | 0.00% | +33.3% |
| Q4 2021 | $11,387,000 | +28.0% | 267,049 | +15.1% | 0.00% | 0.0% |
| Q3 2021 | $8,894,000 | +564.7% | 232,029 | +389.8% | 0.00% | – |
| Q2 2021 | $1,338,000 | +194.1% | 47,377 | +244.1% | 0.00% | – |
| Q1 2021 | $455,000 | -2.8% | 13,767 | +6.3% | 0.00% | – |
| Q4 2020 | $468,000 | – | 12,946 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $366,268,777 | 96.46% |
| venBio Partners LLC | 1,035,396 | $33,805,679 | 18.74% |
| Nan Fung Group Holdings Ltd | 368,665 | $12,036,912 | 8.19% |
| Vivo Capital, LLC | 2,606,247 | $85,093,965 | 5.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 570,500 | $18,621,120 | 5.20% |
| ASHFORD CAPITAL MANAGEMENT INC | 445,418 | $14,542,898 | 2.18% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 678,715 | $22,160,045 | 2.07% |
| TANG CAPITAL MANAGEMENT LLC | 321,200 | $10,487,180 | 1.56% |
| AlphaCentric Advisors LLC | 67,500 | $2,203,875 | 1.52% |
| Paradiem, LLC | 66,995 | $2,187,387 | 0.68% |